Receptors, Artificial
- Name
- Receptors, Artificial
- Accession Number
- DBCAT005634
- Description
Receptors that are created by SYNTHETIC CHEMISTRY TECHNIQUES. They are usually designed to mimic endogenous CELL SURFACE RECEPTORS.
- Drugs
Drug Drug Description Brexucabtagene autoleucel A modified autologous chimeric antigen receptor (CAR) T cell therapy employing a modified murine anti-CD19 single-chain variable fragment linked to CD28 and CD3ΞΆ co-stimulatory domains for the treatment of patients with relapsed and refractory mantle cell lymphoma. Idecabtagene vicleucel An autologous T-cell therapy indicated to treat relapsed or refractory multiple myeloma. - Drugs & Drug Targets
Drug Target Type Brexucabtagene autoleucel B-lymphocyte antigen CD19 target Idecabtagene vicleucel Tumor necrosis factor receptor superfamily member 17 target